Press Release

Aug- 2026 -

26 August

Cision PR Newswire
0

Vivace Therapeutics Strengthens Leadership Team as It Prepares to Advance VT3989, the First TEAD Inhibitor to enter Phase 3 Clinical Trials, as the Leading Treatment for Mesothelioma
Read More »
26 August

Cision PR Newswire
0

Insmed to Present at September 2026 Investor Conferences
Read More »
26 August

Cision PR Newswire
0

Sabio and Gentoro Partner to Advance Agentic AI Across Advertising Operations
Read More »
26 August

Cision PR Newswire
0

LightInTheBox Reports Second Quarter 2026 Financial Results
Read More »
26 August

Cision PR Newswire
0

Dmitry Druzhinsky on Why Winning Young Does Not Always Mean Developing Well
Read More »
26 August

Cision PR Newswire
0

MiniMax Announces First Half 2026 Financial Results
Read More »
26 August

Cision PR Newswire
0

JinkoSolar Announces Second Quarter 2026 Financial Results
Read More »
26 August

Cision PR Newswire
0

JinkoSolar Appoints New Chief Executive Officer
Read More »
26 August

Cision PR Newswire
0

Alebund Pharmaceuticals Announces 2026 Interim Results
Read More »
26 August

Cision PR Newswire
0

Singlewire Software Report Finds K-12 Emergency Readiness Is Built in the Daily Routine
Read More »

Previous page Next page